Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: Preliminary report of the French SAGhE study

Journal of Clinical Endocrinology and Metabolism

Volumn 97, Issue 2, 2012, Pages 416-425

  Carel, Jean Claude ^a   Ecosse, Emmanuel ^b   Landier, Fabienne ^a   Meguellati Hakkas, Djamila ^a   Kaguelidou, Florentia ^a   Rey, Grégoire ^a   Coste, Joël ^b  

^a INSERM   (France)

^b University Paris Descartes ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

RECOMBINANT GROWTH HORMONE;

ARTICLE; BODY HEIGHT; BONE TUMOR; BRAIN HEMORRHAGE; CAUSE OF DEATH; CHILD; CHILDHOOD MORTALITY; CLINICAL EVALUATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE REGISTRY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG USE; FEMALE; FOLLOW UP; FRANCE; GESTATIONAL AGE; GROWTH HORMONE DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; POPULATION RISK; PRIORITY JOURNAL; SHORT STATURE; SUBARACHNOID HEMORRHAGE;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; ALGORITHMS; CAUSE OF DEATH; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; FRANCE; GROWTH DISORDERS; GROWTH HORMONE; HUMAN GROWTH HORMONE; HUMANS; MALE; MIDDLE AGED; POPULATION; RECOMBINANT PROTEINS; TIME FACTORS; YOUNG ADULT;

EID: 84856795770     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2011-1995     Document Type: Article

References (42)

1. Rosenbloom AL 2011 Pediatric endo-cosmetology and the evolution of growth diagnosis and treatment. J Pediatr 158:187-193
2. Guyda HJ 1999 Commentary. Four decades of growth hormone therapy for short children: what haveweachieved? J Clin Endocrinol Metab 84:4307-4316
3. Allen DB 2010 Growth hormone post-marketing surveillance: safety, sales, and the unfinished task ahead. J Clin Endocrinol Metab 95:52-55
4. 2001 Consensus. Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. J Clin Endocrinol Metab 86:1868-1870
5. Bell J, Parker KL, Swinford RD, Hoffman AR, Maneatis T, Lippe B 2010 Long-term safety of recombinant human growth hormone in children. J Clin Endocrinol Metab 95:167-177
6. Wilton P, Mattsson AF, Darendeliler F 2010 Growth hormone treatment in children is not associated with an increase in the incidence of cancer: experience from KIGS (Pfizer International Growth Database). J Pediatr 157:265-270
7. Swerdlow AJ, Higgins CD, Adlard P, Preece MA 2002 Risk of cancer in patients treated with human pituitary growth hormone in the UK, 1959-85: a cohort study. Lancet 360:273-277 (Pubitemid 34879081)
8. Mills JL, Schonberger LB, Wysowski DK, Brown P, Durako SJ, Cox C, Kong F, Fradkin JE 2004 Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr 144:430-436 (Pubitemid 38457343)
9. Ergun-Longmire B, Mertens AC, Mitby P, Qin J, Heller G, Shi W, Yasui Y, Robison LL, Sklar CA 2006 Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor. J Clin Endocrinol Metab 91:3494-3498 (Pubitemid 44402126)
10. Melmed S 2009 Acromegaly pathogenesis and treatment. J Clin Invest 119:3189-3202
11. Sherlock M, Ayuk J, Tomlinson JW, Toogood AA, Aragon-Alonso A, Sheppard MC, Bates AS, Stewart PM 2010 Mortality in patients with pituitary disease. Endocr Rev 31:301-342
12. Guevara-Aguirre J, Balasubramanian P, Guevara-Aguirre M, Wei M, Madia F, Cheng CW, Hwang D, Martin-Montalvo A, Saavedra J, Ingles S, de Cabo R, Cohen P, Longo VD 2011 Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci Transl Med 3:70ra13
13. Pollak MN, Schernhammer ES, Hankinson SE 2004 Insulin-like growth factors and neoplasia. Nat Rev Cancer 4:505-518 (Pubitemid 38868620)
14. Safety and Appropriateness of Growth Hormone Treatments in Europe (SAGhE) study. http://saghe.aphp.fr/site/spip.php/
15. Coste J, Letrait M, Carel JC, Tresca JP, Chatelain P, Rochiccioli P, Chaussain JL, Job JC 1997 Long term results of GH treatment in short stature children: a population register-based study. BMJ 315: 708-713 (Pubitemid 27405825)
16. Carel JC, Ecosse E, Nicolino M, Tauber M, Leger J, Cabrol S, Bastié- Sigeac I, Chaussain JL, Coste J 2002 Adult height after long-term recombinant growth hormone treatment for idiopathic isolated growth hormone deficiency: observational follow-up study of the French population-based registry. BMJ 325:70-73
17. Armstrong DL, Wing SB, Tyroler HA 1995 United States mortality from ill-defined causes, 1968-1988: potential effects on heart disease mortality trends. Int J Epidemiol 24:522-527 (Pubitemid 26429711)
18. D'Amico M, Agozzino E, Biagino A, Simonetti A, Marinelli P 1999 Ill-defined and multiple causes on death certificates-a study of misclassification in mortality statistics. Eur J Epidemiol 15:141-148 (Pubitemid 29124804)
19. Jougla E, Pavillon G, Rossollin F, De Smedt M, Bonte J 1998 Improvement of the quality and comparability of causes-of-death statistics inside the European Community. EUROSTAT Task Force on "causes of death statistics." Revue Epidemiol Sante Publique 46:447-456 (Pubitemid 29042303)
20. Breslow NE, Day NE 1987 Statistical methods in cancer research. Volume II-the design and analysis of cohort studies. IARC Sci Publ 1-406
21. Tomlinson JW, Holden N, Hills RK, Wheatley K, Clayton RN, Bates AS, Sheppard MC, Stewart PM 2001 Association between premature mortality and hypopituitarism. West Midlands Prospective Hypopituitary Study Group. Lancet 357:425-431
22. Rubin D 1987 Multiple imputation for nonresponse in surveys. New York: John Wiley and Sons
23. Shalet SM, Toogood A, Rahim A, Brennan BM 1998 The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 19:203-223 (Pubitemid 29114291)
24. Jousilahti P, Tuomilehto J, Vartiainen E, Eriksson J, Puska P 2000 Relation of adult height to cause-specific and total mortality: a prospective follow-up study of 31,199 middle-aged men and women in Finland. Am J Epidemiol 151:1112-1120 (Pubitemid 30489207)
25. Song YM, Smith GD, Sung J 2003 Adult height and cause-specific mortality: a large prospective study of South Korean men. Am J Epidemiol 158:479-485 (Pubitemid 37022846)
26. Song YM, Sung J 2008 Adult height and the risk of mortality in South Korean women. Am J Epidemiol 168:497-505
27. Jones ME, Swerdlow AJ 1998 Bias in the standardized mortality ratio when using general population rates to estimate expected number of deaths. Am J Epidemiol 148:1012-1017 (Pubitemid 28533742)
28. Green J, Cairns BJ, Casabonne D, Wright FL, Reeves G, Beral V 2011 Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol 12:785-794
29. Tauber M, Moulin P, Pienkowski C, Jouret B, Rochiccioli P 1997 Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. J Clin Endocrinol Metab 82:352-356 (Pubitemid 27068591)
30. Barker DJ, Winter PD, Osmond C, Margetts B, Simmonds SJ 1989 Weight in infancy and death from ischaemic heart disease. Lancet 2:577-580 (Pubitemid 19216205)
31. Barker DJ, Osmond C, Forsén TJ, Kajantie E, Eriksson JG 2005 Trajectories of growth among children who have coronary events as adults. N Engl J Med 353:1802-1809 (Pubitemid 41549892)
32. Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, Guizard AV, Molinié F, Danzon A, Bara S, Bouvier AM, Trétarre B, Binder-Foucard F, Colonna M, Daubisse L, Hédelin G, Launoy G, Le Stang N, Maynadié M, Monnereau A, Troussard X, Faivre J, Collignon A, Janoray I, Arveux P, Buemi A, Raverdy N, Schvartz C, Bovet M, Chérié-Challine L, Estève J, Remontet L, Velten M 2008 Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 56:159-175
33. Longhi A, Pasini A, Cicognani A, Baronio F, Pellacani A, Baldini N, Bacci G 2005 Height as a risk factor for osteosarcoma. J Pediatr Hematol Oncol 27:314-318 (Pubitemid 40885161)
34. Wang Y, Lipari P, Wang X, Hailey J, Liang L, Ramos R, Liu M, Pachter JA, Bishop WR, Wang Y 2010 A fully human insulin-like growth factor-I receptor antibody SCH717454 (robatumumab) has antitumor activity as a single agent and in combination with cytotoxics in pediatric tumor xenografts. Mol Cancer Ther 9:410-418
35. Clemmons DR 2007 Modifying IGF1 activity: an approach to treat endocrine disorders, atherosclerosis and cancer. Nat Rev Drug Discov 6:821-833 (Pubitemid 47500506)
36. Sklar CA, Mertens AC, Mitby P, Occhiogrosso G, Qin J, Heller G, Yasui Y, Robison LL 2002 Risk of disease recurrence and second neoplasms in survivors of childhood cancer treated with growth hormone: a report from the Childhood Cancer Survivor Study. J Clin Endocrinol Metab 87:3136-3141 (Pubitemid 34816355)
37. Erfurth EM, Hagmar L 2005 Cerebrovascular disease in patients with pituitary tumors. Trends Endocrinol Metab 16:334-342 (Pubitemid 41206640)
38. McCarron P, Hart CL, Hole D, Smith GD 2001 The relation between adult height and haemorrhagic and ischaemic stroke in the Renfrew/ Paisley study. J Epidemiol Community Health 55:404-405 (Pubitemid 32472877)
39. Silventoinen K, Magnusson PK, Tynelius P, Batty GD, Rasmussen F 2009 Association of body size and muscle strength with incidence of coronary heart disease and cerebrovascular diseases: a population- based cohort study of one million Swedish men. Int J Epidemiol 38:110-118
40. Hozawa A, Murakami Y, Okamura T, Kadowaki T, Nakamura K, Hayakawa T, Kita Y, Nakamura Y, Okayama A, Ueshima H 2007 Relation of adult height with stroke mortality in Japan: NIPPON DATA80. Stroke 38:22-26 (Pubitemid 46035601)
41. Nutropin product information. http://www.gene.com/gene/products/ information/opportunistic/nutropin/insert.jsp
42. Genotropin product information http://www.pfizer.com/products/ rx/rx-product-genotropin.jsp